Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Benodiazepine spirohydantoin CGRP receptor antagonists

Benodiazepine spirohydantoin CGRP receptor antagonists

US Patent 7205293 · Granted Apr 17, 2007

Estimated economic value: $100,427,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds that interact with the Ras superfamily for the treatment of cancers, i2025
Pyrrolidine orexin receptor agonists2025
Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors2025
2-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitors2025
Compounds for the treatment of cancer and inflammatory disease2024
2-oxoimidazolidine-4-carboxamides as NAv1.8 inhibitors2023
Substituted 6-membered aryl or heteroaryl allosteric modulators of nicotinic ace2023
Compounds for the treatment of cancer and inflammatory disease2023
Compounds that interact with the Ras superfamily for the treatment of cancers, i2023
2-amino-n-heteroaryl-nicotinamides as Nav1.8 inhibitors2022
Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors2022
Compounds that interact with the Ras superfamily for the treatment of cancers, i2022